Liquid Biopsy Summit
(Lisbon, February 20, 2020)
Presentation „Liquid biopsies: Coming of age of promising tools“
Cancer Precision Medicine Forum
(Berlin, December 2, 2019)
Panel discussion: „Examining the influence of current regulatory & policy frameworks in facilitating the progress & implementation of Precision Oncology“
2nd Annual Companion Diagnostics & Biomarker Conference
(Porto, February 14, 2019)
Panel discussion: „Regulation of CDx in the EU“
Biotech Pharma Summit 2017
(Porto, October 26, 2017)
Presentation: „Case Study Companion Diagnostics“
Nordic Precision Medicine Forum
(Copenhagen, April 26, 2017)
Presentation: „Companion Diagnostics – recent advantages and future perspectives”
Pharma Danmark Conference
(Copenhagen, November 5, 2016)
Presentation: „Personalized Medicine – recent advantages and future perspectives”
Medtech & Pharma Platform „Inovative drug-device combinations and diagnostics“
(Basel, September 22-23, 2016)
Presentation: „Companion diagnostics development – current status & future perspective“”
Precision Medicine Congress
(London, September 12-13, 2016)
Panel Discussion: „Advancing Precision Medicine, including NGS, in the Evolving Regulatory Environment”
World CDx Conference
(London, March 15-17, 2016)
Workshop: Drug-Companion Diagnostic Adoption & Reimbursement: „A Comprehensive Guide to the Major European States“
Panel Discussion: „How do we Deal with the Ever-Changing Regulatory Landscape?”
Precision Medicine Congress
(London, September 14-15, 2015)
Panel discussion: „Future of Precision Medicine“
World CDx Conference
(Berlin, March 17-19, 2015)
Workshop: “Operational Management of a CDx program: A comprehensive guide to the major regulatory landscapes“
SBA Academy „Changing paradigms in drug development“
(Bern, February 3, 2015)
Presentation: „Personalized medicine – changing the way drugs are developed and used“
Precision Medicine Congress
(London, May 19-20, 2014)
Panel discussion: “Choosing & Managing RxDx partnerships“
CHI Web Training Course „Use of Companion Diagnostics for Driving Precision Medicine in CNS Disorders“
(April 10, 2014)
Presentation: „CDx Regulatory Framework: Lessons Learned From Oncology“
BioM m4 Strategy Workshop
(Munich, March 19-20, 2014)
Presentation: “Personalised Medicine – a new paradigm in healthcare“
ADAPT Congress Global Strategies for Companion Diagnostics
(Boston, November 4–5, 2013)
Presentation: “The Economic Value within Companion Diagnostics and Stratified Medicines Relationships”
Sachs Annual Biotech in Europe Investor Forum
(Zurich, September 30–0ct. 1, 2013)
Panel Discussion: “Personalised Medicine and Companion Diagnostics: from development to market”
Oncotest Symposium
(Freiburg, April 25–16, 2013)
Presentation: “Overcoming practical hurdles related to the operationalization of Personalized Medicine clinical trials”
Sachs European Lifescience CEO Forum
(Zurich, March 5–6, 2013)
Presentation: “Regenerative medicine – on the cutting edge of healthcare and personalised medicine”
M4 Biomarker Conference
(Munich, November 22–23, 2012)
Panel Discussion: “Molecular imaging for personalized medicine: a doubtful future?“
